Nuveen LLC Buys New Holdings in Quantum-Si Incorporated $QSI

Nuveen LLC bought a new stake in Quantum-Si Incorporated (NASDAQ:QSI) during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 319,100 shares of the company’s stock, valued at approximately $383,000. Nuveen LLC owned approximately 0.17% of Quantum-Si as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. Two Sigma Investments LP purchased a new position in shares of Quantum-Si in the 4th quarter valued at about $412,000. Centiva Capital LP purchased a new position in shares of Quantum-Si in the 4th quarter valued at about $387,000. XTX Topco Ltd increased its holdings in shares of Quantum-Si by 50.2% in the 1st quarter. XTX Topco Ltd now owns 368,968 shares of the company’s stock valued at $443,000 after acquiring an additional 123,383 shares during the last quarter. Green Alpha Advisors LLC raised its holdings in Quantum-Si by 53.6% during the first quarter. Green Alpha Advisors LLC now owns 244,067 shares of the company’s stock worth $293,000 after purchasing an additional 85,209 shares in the last quarter. Finally, EWA LLC acquired a new stake in Quantum-Si during the first quarter worth approximately $94,000. Institutional investors and hedge funds own 39.90% of the company’s stock.

Insider Activity

In other Quantum-Si news, insider John S. Vieceli sold 21,923 shares of the business’s stock in a transaction dated Monday, June 23rd. The stock was sold at an average price of $1.61, for a total transaction of $35,296.03. Following the transaction, the insider owned 842,586 shares in the company, valued at $1,356,563.46. The trade was a 2.54% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Jeffrey Alan Hawkins sold 23,705 shares of Quantum-Si stock in a transaction that occurred on Monday, June 23rd. The shares were sold at an average price of $1.61, for a total transaction of $38,165.05. Following the sale, the chief executive officer owned 2,623,011 shares in the company, valued at $4,223,047.71. This represents a 0.90% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 54,252 shares of company stock worth $87,346. Insiders own 30.04% of the company’s stock.

Quantum-Si Stock Performance

Shares of QSI opened at $1.07 on Friday. The stock has a market capitalization of $216.66 million, a P/E ratio of -1.57 and a beta of 2.85. Quantum-Si Incorporated has a 1 year low of $0.61 and a 1 year high of $5.77. The company’s fifty day moving average is $1.50 and its two-hundred day moving average is $1.47.

Quantum-Si (NASDAQ:QSI) last released its quarterly earnings data on Tuesday, August 5th. The company reported ($0.16) earnings per share for the quarter, meeting the consensus estimate of ($0.16). Quantum-Si had a negative return on equity of 44.57% and a negative net margin of 3,120.14%.The firm had revenue of $0.59 million during the quarter, compared to the consensus estimate of $1.28 million. Sell-side analysts predict that Quantum-Si Incorporated will post -0.65 EPS for the current year.

Analysts Set New Price Targets

A number of research firms have weighed in on QSI. HC Wainwright reissued a “buy” rating and set a $5.50 price objective on shares of Quantum-Si in a report on Monday, May 19th. Alliance Global Partners reissued a “buy” rating on shares of Quantum-Si in a report on Friday, May 16th. Two research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat.com, Quantum-Si presently has a consensus rating of “Moderate Buy” and a consensus target price of $3.48.

About Quantum-Si

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.